The central role of Wnt signaling and organoid technology in personalizing anticancer therapy

Vincan, Elizabeth, Schwab, Renate H.M., Flanagan, Dustin J., Moselen, Jean M., Tran, Bang M., Barker, Nick and Phesse, Toby ORCID: https://orcid.org/0000-0001-9568-4916 2018. The central role of Wnt signaling and organoid technology in personalizing anticancer therapy. Progress in Molecular Biology and Translational Science 153 , pp. 299-319. 10.1016/bs.pmbts.2017.11.009

Preview	PDF - Accepted Post-Print Version Download (231kB) | Preview
Preview	PDF - Supplemental Material Download (56kB) | Preview
Preview	PDF - Supplemental Material Download (83kB) | Preview
Preview	Image (TIFF) - Supplemental Material Download (51kB) | Preview
Preview	Image (TIFF) - Supplemental Material Download (58kB) | Preview
Preview	Image (TIFF) - Supplemental Material Download (386kB) | Preview

Abstract

The Wnt pathway is at the heart of organoid technology, which is set to revolutionize the cancer field. We can now predetermine a patient's response to any given anticancer therapy by exposing tumor organoids established from the patient's own tumor. This cutting-edge biomedical platform translates to patients being treated with the correct drug at the correct dose from the outset, a truly personalized and precise medical approach. A high throughput drug screen on organoids also allows drugs to be tested in limitless combinations. More recently, the tumor cells that are resistant to the therapy given to a patient were selected in culture using the patient's organoids. The resistant tumor organoids were then screened empirically to identify drugs that will kill the resistant cells. This information allows diagnosis in real-time to either prevent tumor recurrence or effectively treat the recurring tumor. Furthermore, the ability to culture stem cell-derived epithelium as organoids has enabled us to begin to understand how a stem cell becomes a cancer cell or to pin-point the genetic alteration that underlies a given genetic syndrome. Here we summarize these advances and the central role of Wnt signaling, and identify the next challenges for organoid technology.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences European Cancer Stem Cell Research Institute (ECSCRI)
Publisher:	Elsevier
ISSN:	1877-1173
Date of First Compliant Deposit:	6 March 2018
Date of Acceptance:	5 March 2018
Last Modified:	06 Nov 2024 14:16
URI:	https://orca.cardiff.ac.uk/id/eprint/109705

Citation Data

Cited 7 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item